Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Pharmacotherapy in Depressed Alcoholics
NCT00006204Phase 4Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Naltrexone + Fluoxetine with Fluoxetine + Placebo (2 arms). Primary endpoints: Alcohol use at 6 months and Depressive symptoms at 6 months. Started Mar 2000; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00006204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006204.